Burkitt’s lymphoma is a fast-growing cancer of the lymphatic system. While it is relatively rare in adults, it is one of the common cancers in children. The chances of cure are high – yet only twenty percent of children who suffer a relapse survive.

With a donation of 40,000 euros, BIOMEX is supporting the excellent work of two university groups investigating on Burkitt’s lymphoma in children:

Prof. Dr. Dr. Birgit Burkhardt’s group from Münster University Hospital (UKM) is trying to understand the genetic mechanisms in the cells that underlie the relapse of affected children.
The group of Prof. Dr. Wilhelm Wößmann from the University Medical Center Hamburg-Eppendorf (UKE) is establishing methods to help identify children at risk of relapse at an early stage.

We are very pleased to be able to contribute to a better understanding of this disease with our donation and wish the two research groups every success with their projects.